Busy Start to the Year on Wall Street
The beginning of the year has been bustling on Wall Street, with an influx of stock upgrades and downgrades. This flurry of street-notes has set the tone for the early…
The beginning of the year has been bustling on Wall Street, with an influx of stock upgrades and downgrades. This flurry of street-notes has set the tone for the early…
Moderna Inc. has recently revealed a strategic reorganization aimed at enhancing focus on two key initiatives: driving sales for its COVID vaccine, Spikevax, and preparing for the anticipated launch of…
Merck & Co. (MRK) and Moderna Inc. (MRNA) have announced the initiation of a Phase 3 trial to evaluate the efficacy of Moderna's V940 in combination with Merck's Keytruda as…
(Moderna) Moderna reported a net income of $3.7 billion in the first quarter of 2022, an increase of more than 300% from $1.2 billion in the prior year. The robust…
(Moderna) Moderna Inc. has announced that the currently authorized 50 µg booster dose increased neutralizing antibodies against the Omicron by about 37 times. The 100-µg dose raised the neutralizing antibodies…
(FT) The European Stoxx 600 share index, Germany’s Dax, and the UK’s FTSE 100 plunged about 1.3% on Tuesday after Moderna CEO said existing vaccines could struggle with the Omicron…
(WSJ) S&P 500 futures fell about 1.6%, while the Dow Jones Industrial Average traded 2.2% lower on Friday on fresh concerns of the spread of a new strain of coronavirus…
(Moderna) US Food and Drug Administration has extended the emergency use authorization of Moderna’s booster vaccine shot against Covid-19. The booster dose will be used on all individuals 18 years…
Moderna stock up 214% ahead of Q3 results.Q3 revenue and earnings are expected to top estimates.Coronavirus vaccine uptake impact on Q3 revenue. Moderna Inc. (NASDAQ: MRNA) is scheduled to report…
(Reuters) Finland has joined Sweden and Denmark as countries pausing the use of Moderna’s Covid-19 vaccine for younger males due to risks of a rare cardiovascular side effect. The move…
(Moderna) Moderna Inc. has agreed with the Government of Canada to supply as much as 105 million doses of its Covid-19 vaccine, upon approval, and its booster vaccine candidate The…
(Bloomberg) US Food and Drug Administration has allowed Moderna Inc., Pfizer Inc., and BioNTech SE vaccines to be given as a third dose to Americans with weak immune systems. The…